HEADER VIRAL PROTEIN/IMMUNE SYSTEM 01-AUG-25 9PV5 TITLE 10E8-GT10.2 IMMUNOGEN IN COMPLEX WITH RHESUS MACAQUE FAB W3-05 AND TITLE 2 MOUSE FAB W6-03 COMPND MOL_ID: 1; COMPND 2 MOLECULE: 10E8-GT10.2 IMMUNOGEN; COMPND 3 CHAIN: C; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: W6-03 MOUSE FAB HEAVY CHAIN; COMPND 7 CHAIN: H; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: W6-03 MOUSE FAB LIGHT CHAIN; COMPND 11 CHAIN: L; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 4; COMPND 14 MOLECULE: W3-05 RHESUS MACAQUE FAB HEAVY CHAIN; COMPND 15 CHAIN: A; COMPND 16 ENGINEERED: YES; COMPND 17 MOL_ID: 5; COMPND 18 MOLECULE: W3-05 RHESUS MACAQUE FAB LIGHT CHAIN; COMPND 19 CHAIN: B; COMPND 20 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 3 ORGANISM_TAXID: 32630; SOURCE 4 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 8 ORGANISM_TAXID: 10090; SOURCE 9 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 11 MOL_ID: 3; SOURCE 12 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 13 ORGANISM_TAXID: 10090; SOURCE 14 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 16 MOL_ID: 4; SOURCE 17 ORGANISM_SCIENTIFIC: MACACA MULATTA; SOURCE 18 ORGANISM_TAXID: 9544; SOURCE 19 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 20 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 21 MOL_ID: 5; SOURCE 22 ORGANISM_SCIENTIFIC: MACACA MULATTA; SOURCE 23 ORGANISM_TAXID: 9544; SOURCE 24 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 25 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS HIV, GERMLINE TARGETING, MPER, BROADLY NEUTRALIZING ANTIBODY, VACCINE KEYWDS 2 DESIGN, VIRAL PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX EXPDTA ELECTRON MICROSCOPY AUTHOR J.HUANG,A.B.WARD REVDAT 1 10-DEC-25 9PV5 0 JRNL AUTH J.HUANG JRNL TITL DECIPHER ANTIBODY RESPONSES PRIMED WITH SCAFFOLDS HARBORING JRNL TITL 2 THE GERMLINE-TARGETING HIV ENV MPER EPITOPE BY CRYOEM JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH T.SCHIFFNER,I.PHUNG,R.RAY,A.IRIMIA,M.TIAN,O.SWANSON,J.H.LEE, REMARK 1 AUTH 2 C.D.LEE,E.MARINA-ZARATE,S.Y.CHO,J.HUANG,G.OZOROWSKI, REMARK 1 AUTH 3 P.D.SKOG,A.M.SERRA,K.RANTALAINEN,J.D.ALLEN,S.BABOO, REMARK 1 AUTH 4 O.L.RODRIGUEZ,S.HIMANSU,J.ZHOU,J.HURTADO,C.T.FLYNN, REMARK 1 AUTH 5 K.MCKENNEY,C.HAVENAR-DAUGHTON,S.SAHA,K.SHIELDS,S.SCHULTZE, REMARK 1 AUTH 6 M.L.SMITH,C.H.LIANG,L.TOY,S.PECETTA,Y.C.LIN,J.R.WILLIS, REMARK 1 AUTH 7 F.SESTERHENN,D.W.KULP,X.HU,C.A.COTTRELL,X.ZHOU,J.RUIZ, REMARK 1 AUTH 8 X.WANG,U.NAIR,K.H.KIRSCH,H.L.CHENG,J.DAVIS,O.KALYUZHNIY, REMARK 1 AUTH 9 A.LIGUORI,J.K.DIEDRICH,J.T.NGO,V.LEWIS,N.PHELPS,R.D.TINGLE, REMARK 1 AUTH10 S.SPENCER,E.GEORGESON,Y.ADACHI,M.KUBITZ,S.ESKANDARZADEH, REMARK 1 AUTH11 M.A.ELSLIGER,R.R.AMARA,E.LANDAIS,B.BRINEY,D.R.BURTON, REMARK 1 AUTH12 D.G.CARNATHAN,G.SILVESTRI,C.T.WATSON,J.R.YATES,J.C.PAULSON, REMARK 1 AUTH13 M.CRISPIN,G.GRIGORYAN,A.B.WARD,D.SOK,F.W.ALT,I.A.WILSON, REMARK 1 AUTH14 F.D.BATISTA,S.CROTTY,W.R.SCHIEF REMARK 1 TITL VACCINATION INDUCES BROADLY NEUTRALIZING ANTIBODY PRECURSORS REMARK 1 TITL 2 TO HIV GP41. REMARK 1 REF NAT IMMUNOL V. 25 1073 2024 REMARK 1 REFN ESSN 1529-2916 REMARK 1 PMID 38816615 REMARK 1 DOI 10.1016/J.CELREP.2020.108122 REMARK 2 REMARK 2 RESOLUTION. 3.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : EPU, CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.900 REMARK 3 NUMBER OF PARTICLES : 41951 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9PV5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-AUG-25. REMARK 100 THE DEPOSITION ID IS D_1000291799. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : 10E8-GT10.2 IMMUNOGEN IN REMARK 245 COMPLEX WITH MOUSE FAB W6-03 REMARK 245 AND RHESUS MACAQUE FAB W3-05; REMARK 245 W6-03 MOUSE FAB HEAVY CHAIN, W6- REMARK 245 03 MOUSE FAB LIGHT CHAIN; 10E8- REMARK 245 GT10.2 IMMUNOGEN; W3-05 RHESUS REMARK 245 MACAQUE FAB HEAVY CHAIN, W3-05 REMARK 245 RHESUS MACAQUE FAB LIGHT CHAIN REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 4.40 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS GLACIOS REMARK 245 DETECTOR TYPE : FEI FALCON IV (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 700.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 1500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5040.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 200 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: PENTAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, H, L, A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR C 1 REMARK 465 GLY C 2 REMARK 465 ASN C 3 REMARK 465 SER H 126 REMARK 465 SER H 127 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG1 THR H 91 OG1 THR H 124 2.02 REMARK 500 OH TYR L 42 OH TYR L 97 2.11 REMARK 500 OE2 GLU C 151 OG SER L 32 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 PRO B 43 CG PRO B 43 CD -0.229 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO L 46 CA - N - CD ANGL. DEV. = -9.0 DEGREES REMARK 500 CYS L 94 CA - CB - SG ANGL. DEV. = 8.3 DEGREES REMARK 500 PRO B 43 CA - CB - CG ANGL. DEV. = -13.3 DEGREES REMARK 500 PRO B 43 N - CD - CG ANGL. DEV. = -15.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP C 26 -45.64 67.68 REMARK 500 PHE C 27 -46.50 71.11 REMARK 500 VAL C 66 -83.71 -124.51 REMARK 500 TRP C 78 -60.02 -122.04 REMARK 500 TYR H 33 164.40 67.04 REMARK 500 TYR H 113 -0.63 66.05 REMARK 500 SER L 9 16.20 59.70 REMARK 500 SER L 10 -142.65 58.11 REMARK 500 LEU L 29 14.04 57.52 REMARK 500 TYR L 42 65.72 37.75 REMARK 500 SER L 62 59.70 -90.51 REMARK 500 SER L 71 -29.32 -149.92 REMARK 500 THR L 75 -140.13 41.24 REMARK 500 SER L 82 178.46 72.45 REMARK 500 VAL A 2 -52.62 70.03 REMARK 500 LYS A 43 -162.76 -118.68 REMARK 500 SER A 109 -63.73 -151.38 REMARK 500 ASP A 118 -80.69 -113.81 REMARK 500 TYR B 2 -135.95 58.61 REMARK 500 ASN B 26 108.55 -167.15 REMARK 500 ASP B 50 -102.39 57.46 REMARK 500 THR B 73 104.67 71.71 REMARK 500 ALA B 79 -123.54 46.14 REMARK 500 ASP B 95 -1.58 67.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-71883 RELATED DB: EMDB REMARK 900 10E8-GT10.2 IMMUNOGEN IN COMPLEX WITH RHESUS MACAQUE FAB W3-05 AND REMARK 900 MOUSE FAB W6-03 DBREF 9PV5 C 1 157 PDB 9PV5 9PV5 1 157 DBREF 9PV5 H 1 127 PDB 9PV5 9PV5 1 127 DBREF 9PV5 L 1 113 PDB 9PV5 9PV5 1 113 DBREF 9PV5 A 1 130 PDB 9PV5 9PV5 1 130 DBREF 9PV5 B 1 108 PDB 9PV5 9PV5 1 108 SEQRES 1 C 157 THR GLY ASN VAL THR GLN GLU ASP ILE ILE ARG ALA LEU SEQRES 2 C 157 ALA SER PRO LEU ILE LYS ASP GLY MET VAL ASP GLU ASP SEQRES 3 C 157 PHE ALA GLU TYR VAL ILE ALA ARG GLU ASN ARG SER PRO SEQRES 4 C 157 THR GLY LEU GLN ALA LYS GLY VAL GLY VAL ALA ILE PRO SEQRES 5 C 157 HIS THR LEU GLY ASP TYR VAL ARG ASP ASN ALA ILE SER SEQRES 6 C 157 VAL GLY ILE LEU ASP LYS PRO VAL ASN PHE SER GLY TRP SEQRES 7 C 157 TYR GLN SER PRO ASP PRO VAL PRO VAL ARG VAL VAL PHE SEQRES 8 C 157 MET LEU ALA GLY ARG THR TRP ASP ASP ILE VAL ILE VAL SEQRES 9 C 157 LEU LYS TRP ILE LYS ASP VAL ILE LEU ASP GLU GLU PHE SEQRES 10 C 157 MET LYS ARG LEU LEU ASN MET SER ASP GLU GLU ILE TYR SEQRES 11 C 157 ARG GLN ILE TYR THR ARG ILE SER LYS ALA PRO ASN LEU SEQRES 12 C 157 SER GLY ILE ASN PHE SER ARG GLU TYR VAL ARG HIS LEU SEQRES 13 C 157 ASN SEQRES 1 H 127 ASP VAL GLN LEU GLN GLU SER GLY PRO GLY LEU VAL LYS SEQRES 2 H 127 PRO SER GLN SER LEU SER LEU THR CYS SER VAL THR GLY SEQRES 3 H 127 TYR SER ILE THR SER GLY TYR TYR TRP ASN TRP ILE ARG SEQRES 4 H 127 GLN PHE PRO GLY ASN LYS LEU GLU TRP MET GLY TYR ILE SEQRES 5 H 127 SER TYR ASP GLY SER ASN ASN TYR ASN PRO SER LEU LYS SEQRES 6 H 127 ASN ARG ILE SER ILE THR ARG ASP THR SER GLN ASN GLN SEQRES 7 H 127 PHE PHE LEU LYS LEU ASN SER VAL THR THR GLU ASP THR SEQRES 8 H 127 ALA SER TYR TYR CYS ALA ARG GLU GLY PRO TYR TYR ASP SEQRES 9 H 127 PHE TRP SER GLY TYR TYR ALA TYR TYR MET ASP VAL TRP SEQRES 10 H 127 GLY LYS GLY THR THR VAL THR VAL SER SER SEQRES 1 L 113 ASP ILE VAL MET SER GLN SER PRO SER SER LEU ALA VAL SEQRES 2 L 113 SER VAL GLY GLU LYS VAL THR MET SER CYS LYS SER SER SEQRES 3 L 113 GLN SER LEU LEU TYR SER SER ASN GLN LYS ASN TYR LEU SEQRES 4 L 113 ALA TRP TYR GLN GLN LYS PRO GLY GLN SER PRO LYS LEU SEQRES 5 L 113 LEU ILE TYR TRP ALA SER THR ARG LYS SER GLY VAL PRO SEQRES 6 L 113 ASP ARG PHE THR GLY SER GLY SER GLY THR ASP PHE THR SEQRES 7 L 113 LEU THR ILE SER SER VAL LYS ALA GLU ASP LEU ALA VAL SEQRES 8 L 113 TYR TYR CYS GLN GLN TYR PHE GLY TYR PRO LEU THR PHE SEQRES 9 L 113 GLY ALA GLY THR LYS LEU GLU LEU LYS SEQRES 1 A 130 GLU VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 A 130 PRO GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 A 130 PHE THR PHE SER ASN TYR TRP MET SER TRP VAL ARG GLN SEQRES 4 A 130 ALA PRO GLY LYS GLY LEU GLU TRP VAL GLY PHE ILE LYS SEQRES 5 A 130 ASN LYS ALA ASP GLY GLY THR ALA ALA TYR ALA GLU SER SEQRES 6 A 130 VAL LYS GLY ARG PHE THR ILE SER ARG ASP ASP SER LYS SEQRES 7 A 130 ASN THR LEU TYR LEU GLN MET ASN SER LEU LYS THR GLU SEQRES 8 A 130 ASP THR ALA VAL TYR TYR CYS ALA ARG ASP LEU GLY ARG SEQRES 9 A 130 TYR ASN PHE TRP SER GLY PHE TYR SER GLN ASN ARG PHE SEQRES 10 A 130 ASP VAL TRP GLY PRO GLY VAL LEU VAL THR VAL SER SER SEQRES 1 B 108 SER TYR GLU VAL THR GLN PRO PRO SER VAL SER VAL SER SEQRES 2 B 108 PRO GLY GLN MET ALA ARG ILE THR CYS GLY GLY ASP ASN SEQRES 3 B 108 LEU GLY SER LYS TYR VAL HIS TRP TYR GLN GLN LYS PRO SEQRES 4 B 108 ALA GLN ALA PRO VAL LEU VAL ILE TYR ASP ASP SER GLU SEQRES 5 B 108 ARG PRO SER GLY ILE PRO GLU ARG PHE SER GLY SER LYS SEQRES 6 B 108 SER GLY ASN THR ALA THR LEU THR ILE SER GLY VAL GLU SEQRES 7 B 108 ALA GLY ASP GLU ALA ASP TYR TYR CYS GLN VAL TRP ASP SEQRES 8 B 108 SER SER SER ASP HIS PRO LEU PHE GLY GLY GLY THR ARG SEQRES 9 B 108 LEU THR VAL LEU HET NAG C 201 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 6 NAG C8 H15 N O6 HELIX 1 AA1 THR C 5 LYS C 19 1 15 HELIX 2 AA2 PHE C 27 SER C 38 1 12 HELIX 3 AA3 THR C 97 LEU C 113 1 17 HELIX 4 AA4 ASP C 114 MET C 124 1 11 HELIX 5 AA5 SER C 125 ALA C 140 1 16 HELIX 6 AA6 SER C 149 VAL C 153 5 5 HELIX 7 AA7 SER H 28 GLY H 32 5 5 HELIX 8 AA8 THR H 87 THR H 91 5 5 HELIX 9 AA9 THR A 28 TYR A 32 5 5 HELIX 10 AB1 ASN A 53 GLY A 57 5 5 HELIX 11 AB2 LYS A 89 THR A 93 5 5 HELIX 12 AB3 ASP B 91 ASP B 95 5 5 SHEET 1 AA1 2 ILE C 64 SER C 65 0 SHEET 2 AA1 2 MET C 92 LEU C 93 -1 O MET C 92 N SER C 65 SHEET 1 AA2 4 GLN H 5 SER H 7 0 SHEET 2 AA2 4 LEU H 18 SER H 23 -1 O SER H 23 N GLN H 5 SHEET 3 AA2 4 GLN H 78 LEU H 83 -1 O LEU H 81 N LEU H 20 SHEET 4 AA2 4 ILE H 68 ASP H 73 -1 N SER H 69 O LYS H 82 SHEET 1 AA3 2 LEU H 11 VAL H 12 0 SHEET 2 AA3 2 VAL H 123 THR H 124 1 N VAL H 123 O VAL H 12 SHEET 1 AA4 5 ASN H 58 ASN H 59 0 SHEET 2 AA4 5 LEU H 46 SER H 53 -1 N TYR H 51 O ASN H 59 SHEET 3 AA4 5 TYR H 34 GLN H 40 -1 N TRP H 35 O ILE H 52 SHEET 4 AA4 5 SER H 93 GLU H 99 -1 O SER H 93 N GLN H 40 SHEET 5 AA4 5 VAL H 116 TRP H 117 -1 O VAL H 116 N ARG H 98 SHEET 1 AA5 3 MET L 4 GLN L 6 0 SHEET 2 AA5 3 THR L 20 SER L 25 -1 O LYS L 24 N SER L 5 SHEET 3 AA5 3 PHE L 77 THR L 80 -1 O PHE L 77 N CYS L 23 SHEET 1 AA6 3 LEU L 39 ALA L 40 0 SHEET 2 AA6 3 ALA L 90 GLN L 96 -1 O GLN L 95 N ALA L 40 SHEET 3 AA6 3 GLY L 105 LYS L 109 -1 O GLY L 107 N TYR L 92 SHEET 1 AA7 4 VAL A 5 SER A 7 0 SHEET 2 AA7 4 LEU A 18 ALA A 23 -1 O SER A 21 N SER A 7 SHEET 3 AA7 4 THR A 80 MET A 85 -1 O MET A 85 N LEU A 18 SHEET 4 AA7 4 PHE A 70 ASP A 75 -1 N THR A 71 O GLN A 84 SHEET 1 AA8 6 GLY A 10 LEU A 11 0 SHEET 2 AA8 6 VAL A 124 THR A 127 1 O LEU A 125 N GLY A 10 SHEET 3 AA8 6 ALA A 94 ASP A 101 -1 N TYR A 96 O VAL A 124 SHEET 4 AA8 6 TRP A 33 GLN A 39 -1 N VAL A 37 O TYR A 97 SHEET 5 AA8 6 GLU A 46 ILE A 51 -1 O GLU A 46 N ARG A 38 SHEET 6 AA8 6 ALA A 60 TYR A 62 -1 O ALA A 61 N PHE A 50 SHEET 1 AA9 5 SER B 9 SER B 11 0 SHEET 2 AA9 5 LEU B 98 THR B 106 1 O ARG B 104 N VAL B 10 SHEET 3 AA9 5 ASP B 84 VAL B 89 -1 N VAL B 89 O LEU B 98 SHEET 4 AA9 5 VAL B 32 GLN B 37 -1 N GLN B 37 O ASP B 84 SHEET 5 AA9 5 PRO B 43 ILE B 47 -1 O VAL B 44 N GLN B 36 SHEET 1 AB1 2 THR B 21 CYS B 22 0 SHEET 2 AB1 2 ALA B 70 THR B 71 -1 O ALA B 70 N CYS B 22 SSBOND 1 CYS H 22 CYS H 96 1555 1555 2.02 SSBOND 2 CYS L 23 CYS L 94 1555 1555 2.02 SSBOND 3 CYS A 22 CYS A 98 1555 1555 2.02 SSBOND 4 CYS B 22 CYS B 87 1555 1555 2.04 LINK ND2 ASN C 74 C1 NAG C 201 1555 1555 1.44 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 TER 1237 ASN C 157 TER 2253 VAL H 125 TER 3126 LYS L 113 TER 4139 SER A 130 TER 4954 LEU B 108 HETATM 4955 C1 NAG C 201 150.103 177.629 116.975 1.00 78.26 C HETATM 4956 C2 NAG C 201 150.680 178.931 116.445 1.00 78.26 C HETATM 4957 C3 NAG C 201 149.542 179.900 116.169 1.00 78.26 C HETATM 4958 C4 NAG C 201 148.584 179.275 115.165 1.00 78.26 C HETATM 4959 C5 NAG C 201 148.069 177.949 115.723 1.00 78.26 C HETATM 4960 C6 NAG C 201 147.181 177.204 114.754 1.00 78.26 C HETATM 4961 C7 NAG C 201 152.940 179.266 117.353 1.00 78.26 C HETATM 4962 C8 NAG C 201 153.760 179.941 118.411 1.00 78.26 C HETATM 4963 N2 NAG C 201 151.624 179.506 117.390 1.00 78.26 N HETATM 4964 O3 NAG C 201 150.065 181.118 115.650 1.00 78.26 O HETATM 4965 O4 NAG C 201 147.484 180.146 114.931 1.00 78.26 O HETATM 4966 O5 NAG C 201 149.182 177.086 116.012 1.00 78.26 O HETATM 4967 O6 NAG C 201 146.077 177.999 114.344 1.00 78.26 O HETATM 4968 O7 NAG C 201 153.445 178.531 116.510 1.00 78.26 O CONECT 536 4955 CONECT 1395 2007 CONECT 2007 1395 CONECT 2413 2972 CONECT 2972 2413 CONECT 3277 3876 CONECT 3876 3277 CONECT 4300 4793 CONECT 4793 4300 CONECT 4955 536 4956 4966 CONECT 4956 4955 4957 4963 CONECT 4957 4956 4958 4964 CONECT 4958 4957 4959 4965 CONECT 4959 4958 4960 4966 CONECT 4960 4959 4967 CONECT 4961 4962 4963 4968 CONECT 4962 4961 CONECT 4963 4956 4961 CONECT 4964 4957 CONECT 4965 4958 CONECT 4966 4955 4959 CONECT 4967 4960 CONECT 4968 4961 MASTER 233 0 1 12 36 0 0 6 4963 5 23 51 END